Compare · HTFL vs SYK
HTFL vs SYK
Side-by-side comparison of Heartflow Inc. (HTFL) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HTFL and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK is the larger of the two at $122.63B, about 57.2x HTFL ($2.15B).
- Both names hit the wire about 5 times in the past 4 weeks.
- SYK has more recent analyst coverage (25 ratings vs 7 for HTFL).
- Company
- Heartflow Inc.
- Stryker Corporation
- Price
- -
- -
- Market cap
- $2.15B
- $122.63B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 5
- 5
- Recent ratings
- 7
- 25
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest HTFL
- Chief Medical Officer Rogers Campbell exercised 9,219 shares at a strike of $19.00 and sold $237,113 worth of shares (9,219 units at $25.72) as part of a pre-agreed trading plan (SEC Form 4)
- Chief Executive Officer Farquhar John C.M. sold $626,096 worth of shares (22,562 units at $27.75) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 435,373 units (SEC Form 4)
- Director Weldon William C exercised 51,369 shares at a strike of $8.33, increasing direct ownership by 27% to 243,931 units (SEC Form 4)
- New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management
- Chief Executive Officer Farquhar John C.M. sold $1,361,500 worth of shares (38,900 units at $35.00) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 457,935 units (SEC Form 4)
- SEC Form 4 filed by Director Weldon William C
- SEC Form 4 filed by Director Barabe Timothy C
- SEC Form 4 filed by Director Cullivan Julie A
- SEC Form 4 filed by Director Lightcap Jeffrey C
- SEC Form 4 filed by Director Riley Wayne Joseph
Latest SYK
- Stryker expands Mako robotics portfolio with full market release of Mako RPS
- BMO Capital Markets initiated coverage on Stryker with a new price target
- Stryker to announce second quarter 2026 financial results
- Stryker Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement
- Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
- President and COO Stiles Spencer S gifted 1,607 shares, decreasing direct ownership by 2% to 76,027 units (SEC Form 4)
- Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
- VP, Chief Legal Officer Fletcher Robert S sold $1,394,409 worth of shares (4,544 units at $306.87) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 10,582 units (SEC Form 4)
- Director Stryker Ronda E sold $96,792,669 worth of shares (310,000 units at $312.23) (SEC Form 4)